A citation-based method for searching scientific literature

Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
Times Cited: 109







List of co-cited articles
589 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
297
27

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
166
24


Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
89
19

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
318
15

Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
Elke M van Veen, Adam R Brentnall, Helen Byers, Elaine F Harkness, Susan M Astley, Sarah Sampson, Anthony Howell, William G Newman, Jack Cuzick, D Gareth R Evans. JAMA Oncol 2018
61
24

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Amy Trentham-Dietz, Karla Kerlikowske, Natasha K Stout, Diana L Miglioretti, Clyde B Schechter, Mehmet Ali Ergun, Jeroen J van den Broek, Oguzhan Alagoz, Brian L Sprague, Nicolien T van Ravesteyn,[...]. Ann Intern Med 2016
70
20


A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
684
13

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
92
14

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
348
12

10-year performance of four models of breast cancer risk: a validation study.
Mary Beth Terry, Yuyan Liao, Alice S Whittemore, Nicole Leoce, Richard Buchsbaum, Nur Zeinomar, Gillian S Dite, Wendy K Chung, Julia A Knight, Melissa C Southey,[...]. Lancet Oncol 2019
69
17

Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.
Ewan Gray, Anna Donten, Nico Karssemeijer, Carla van Gils, D Gareth Evans, Sue Astley, Katherine Payne. Value Health 2017
27
44

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
D Gareth R Evans, Elaine F Harkness, Adam R Brentnall, Elke M van Veen, Susan M Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J Howell,[...]. Breast Cancer Res Treat 2019
28
42

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
12

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Paige Maas, Myrto Barrdahl, Amit D Joshi, Paul L Auer, Mia M Gaudet, Roger L Milne, Fredrick R Schumacher, William F Anderson, David Check, Subham Chattopadhyay,[...]. JAMA Oncol 2016
162
11

Developing and evaluating polygenic risk prediction models for stratified disease prevention.
Nilanjan Chatterjee, Jianxin Shi, Montserrat García-Closas. Nat Rev Genet 2016
316
11

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
466
11

Association analysis identifies 65 new breast cancer risk loci.
Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar,[...]. Nature 2017
549
11

Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
Susanne F Meisel, Nora Pashayan, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. Breast 2015
34
32

A systematic review and quality assessment of individualised breast cancer risk prediction models.
Javier Louro, Margarita Posso, Michele Hilton Boon, Marta Román, Laia Domingo, Xavier Castells, María Sala. Br J Cancer 2019
42
26

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
51
21


Stratified cancer screening: the practicalities of implementation.
T Dent, J Jbilou, I Rafi, N Segnan, S Törnberg, S Chowdhury, A Hall, G Lyratzopoulos, R Eeles, D Eccles,[...]. Public Health Genomics 2013
37
27

Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.
Parichoy Pal Choudhury, Amber N Wilcox, Mark N Brook, Yan Zhang, Thomas Ahearn, Nick Orr, Penny Coulson, Minouk J Schoemaker, Michael E Jones, Mitchell H Gail,[...]. J Natl Cancer Inst 2020
41
24


Breast cancer risk feedback to women in the UK NHS breast screening population.
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
45
20

Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
Tom Callender, Mark Emberton, Steve Morris, Ros Eeles, Zsofia Kote-Jarai, Paul D P Pharoah, Nora Pashayan. PLoS Med 2019
27
33

The contributions of breast density and common genetic variation to breast cancer risk.
Celine M Vachon, V Shane Pankratz, Christopher G Scott, Lothar Haeberle, Elad Ziv, Matthew R Jensen, Kathleen R Brandt, Dana H Whaley, Janet E Olson, Katharina Heusinger,[...]. J Natl Cancer Inst 2015
117
8

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.
Anja Rudolph, Minsun Song, Mark N Brook, Roger L Milne, Nasim Mavaddat, Kyriaki Michailidou, Manjeet K Bolla, Qin Wang, Joe Dennis, Amber N Wilcox,[...]. Int J Epidemiol 2018
48
16

Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer.
Montserrat Garcia-Closas, Necdet Burak Gunsoy, Nilanjan Chatterjee. J Natl Cancer Inst 2014
75
10

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
314
8


Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
8

The personal and clinical utility of polygenic risk scores.
Ali Torkamani, Nathan E Wineinger, Eric J Topol. Nat Rev Genet 2018
488
8

Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Xuehong Zhang, Megan Rice, Shelley S Tworoger, Bernard A Rosner, A Heather Eliassen, Rulla M Tamimi, Amit D Joshi, Sara Lindstrom, Jing Qian, Graham A Colditz,[...]. PLoS Med 2018
48
16

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.
Marie Koitsalu, Mirjam A G Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik Grönberg, Yvonne Brandberg. Acta Oncol 2016
25
32

A response to "Personalised medicine and population health: breast and ovarian cancer".
Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, Mireille Broeders, Jennifer Brooks, Anna Chiarelli, Jocelyne Chiquette, Jack Cuzick, Suzette Delaloge, Peter Devilee,[...]. Hum Genet 2019
11
72

Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey.
Alex Ghanouni, Saskia C Sanderson, Nora Pashayan, Cristina Renzi, Christian von Wagner, Jo Waller. J Med Screen 2020
14
57

Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Tatiane Yanes, Mary-Anne Young, Bettina Meiser, Paul A James. Breast Cancer Res 2020
41
19

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
529
7

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Roger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon, Penny Soucy, Joe Dennis,[...]. Nat Genet 2017
159
7

Polygenic susceptibility to breast cancer and implications for prevention.
Paul D P Pharoah, Antonis Antoniou, Martin Bobrow, Ron L Zimmern, Douglas F Easton, Bruce A J Ponder. Nat Genet 2002
577
7

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
Kevin C Oeffinger, Elizabeth T H Fontham, Ruth Etzioni, Abbe Herzig, James S Michaelson, Ya-Chen Tina Shih, Louise C Walter, Timothy R Church, Christopher R Flowers, Samuel J LaMonte,[...]. JAMA 2015
781
7

Breast-cancer screening--viewpoint of the IARC Working Group.
Béatrice Lauby-Secretan, Chiara Scoccianti, Dana Loomis, Lamia Benbrahim-Tallaa, Véronique Bouvard, Franca Bianchini, Kurt Straif. N Engl J Med 2015
367
7

Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C Gard, Jessica W T Leung, Jeffrey A Tice, Celine M Vachon, Steven R Cummings, Karla Kerlikowske,[...]. Breast Cancer Res Treat 2016
73
9

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.
Jessica A Cintolo-Gonzalez, Danielle Braun, Amanda L Blackford, Emanuele Mazzola, Ahmet Acar, Jennifer K Plichta, Molly Griffin, Kevin S Hughes. Breast Cancer Res Treat 2017
77
9

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.
N Pashayan, S W Duffy, S Chowdhury, T Dent, H Burton, D E Neal, D F Easton, R Eeles, P Pharoah. Br J Cancer 2011
120
7

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.
Nora Pashayan, Stephen W Duffy, David E Neal, Freddie C Hamdy, Jenny L Donovan, Richard M Martin, Patricia Harrington, Sara Benlloch, Ali Amin Al Olama, Mitul Shah,[...]. Genet Med 2015
61
11

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.
Amit V Khera, Mark Chaffin, Krishna G Aragam, Mary E Haas, Carolina Roselli, Seung Hoan Choi, Pradeep Natarajan, Eric S Lander, Steven A Lubitz, Patrick T Ellinor,[...]. Nat Genet 2018
946
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.